Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis

• Ricardo D. Parrondo,
• Keren Sam,
• Ahsan Rasheed,
• Victoria Alegria,
• Taimur Sher,
• Vivek Roy,
• Asher Chanan-Khan,
• Sikander Ailawadhi

Affiliations

Ricardo D. Parrondo

Division of Hematology-Oncology, Mayo Clinic

Keren Sam

Division of Hematology-Oncology, Mayo Clinic

Ahsan Rasheed

Division of Hematology-Oncology, Mayo Clinic

Victoria Alegria

Division of Hematology-Oncology, Mayo Clinic

Taimur Sher

Division of Hematology-Oncology, Mayo Clinic

Vivek Roy

Division of Hematology-Oncology, Mayo Clinic

Asher Chanan-Khan

Division of Hematology-Oncology, Mayo Clinic

Sikander Ailawadhi

Division of Hematology-Oncology, Mayo Clinic